Cost-effectiveness of respiratory syncytial virus vaccination strategies for older Canadian adults: A multi-model comparison
A multi-model comparison of Canadian cost-utility models shows that RSV vaccination programs for RSV are likely cost-effective for some groups of older adults in Canada. These findings were consistent across models, despite differences in model structure.
Authors
- Alison E. Simmons (ORCID: https://orcid.org/0000-0001-8780-9467)
- Gebremedhin Beedemariam Gebretekle (ORCID: https://orcid.org/0000-0002-2485-505X)
- Ashleigh R. Tuite (ORCID: https://orcid.org/0000-0002-4373-9337)
- Monica Rudd
Institutions
- 3M (United States) (US)
- Public Health Agency of Canada (CA)
- University of Toronto (CA)
Publication Details
- Journal
- Canada Communicable Disease Report
- Published
- 2025-02-12
- DOI
- https://doi.org/10.14745/ccdr.v51i23a01
- Citations
- 4
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 5.42
Funders
- Pfizer
- Pfizer Canada